2011Chinese journal of integrated traditional and Western medicineRequires access

Treatment for liver fibrosis of chronic hepatitis B with Adefovir Dipivoxil Capsule and Ganfu Capsule

Hua Peng

Open publisher page 0 citations

Abstract

[Objective]To study the effect of the treatment for liver fibrosis of chronic hepatitis B with Adefovir Dipivoxil Capsule and Ganfu Capsule.[Methods]Total 67 cases were divided into two groups,the treatment(n=37)and control group(n=30).Except for Adefovir Dipivoxil Capsule,which was given to both of two groups,the treatment group was administrated with Ganfu Capsule.The therapy course was 48 weeks for both guoups,and then indexes of hepatofibrosis,clinical manifestation,the index of liver function and HBV-DNA were evaluated.[Results]Clinical symptoms,the index of liver function and hepatic fibrosis in treatment group were obviously improved with a significant difference than control group(P0.05).[Conclusion]Ganfu Capsule combined with Adefovir Dipivoxil Capsule can significantly improve liver fibrosis of chronic hepatitis B and without any obviously side effects.

About this research paper

What this paper is about

[Objective]To study the effect of the treatment for liver fibrosis of chronic hepatitis B with Adefovir Dipivoxil Capsule and Ganfu Capsule.[Methods]Total 67 cases were divided into two groups,the treatment(n=37)and control group(n=30).Except for Adefovir Dipivoxil Capsule,which was given to both of two groups,the treatment group was administrated with Ganfu Capsule.The therapy course was 48 weeks for both guoups,and then indexes of hepatofibrosis,clinical manifestation,the index of liver function and HBV-DNA were evaluated.[Results]Clinical symptoms,the index of liver function and hepatic fibrosis in treatment group were obviously improved with a significant difference than control group(P0.05).[Conclusion]Ganfu Capsule combined with Adefovir Dipivoxil Capsule can significantly improve liver fibrosis of chronic hepatitis B and without any obviously side effects.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective]To study the effect of the treatment for liver fibrosis of chronic hepatitis B with Adefovir Dipivoxil Capsule and Ganfu Capsule.[Methods]Total 67 cases were divided into two groups,the treatment(n=37)and control group(n=30).Except for Adefovir Dipivoxil Capsule,which was given to both of two groups,the treatment group was administrated with Ganfu Capsule.The therapy course was 48 weeks for both guoups,and then indexes of hepatofibrosis,clinical manifestation,the index of liver function and HBV-DNA were evaluated.[Results]Clinical symptoms,the index of liver function and hepatic fibrosis in treatment group were obviously improved with a significant difference than control group(P0.05).[Conclusion]Ganfu Capsule combined with Adefovir Dipivoxil Capsule can significantly improve liver fibrosis of chronic hepatitis B and without any obviously side effects.

Key concepts: Adefovir, Capsule, Gastroenterology, Liver function, Medicine, Internal medicine, Chronic hepatitis, Fibrosis

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment for liver fibrosis of chronic hepatitis B with Adefovir Dipivoxil Capsule and Ganfu Capsule — Research Paper | ScholarLens